|
|||||||||||||||
|
In order to register data in Cristin, you must be an academic or administrative employee.
|
|||||||||||||||
|
|||||||||||||||
|
|||||||||||||||
|
2022
|
||
| 1. | Nordgård, Oddmund; Lapin, Morten; Tjensvoll, Kjersti; Oltedal, Satu; Edland, Karin Hestnes; Neverdahl, Nicolay Bore; Fostenes, Dmitrij; Garresori, Herish; Glenjen, Nils; Smaaland, Rune; Gilje, Bjørnar. Prognostic value of disseminated tumor cells in unresectable pancreatic ductal adenocarcinoma: a prospective observational study. BMC Cancer 2022 ;Volume 22.(1) p. - UIS SUS HAUKELAND |
|
|
2018
|
||
| 2. | Lapin, Morten; Oltedal, Satu; Tjensvoll, Kjersti; Buhl, Tove; Smaaland, Rune; Ahmed, Herish; Javle, Milind; Glenjen, Nils; Abelseth, Bente Kristin; Gilje, Bjørnar; Nordgård, Oddmund. Fragment size and level of cell-free DNA provide prognostic information in patients with advanced pancreatic cancer. Journal of Translational Medicine 2018 ;Volume 16:300. p. 1-10 HAUKELAND SUS |
|
|
|
||
| 3. | Lapin, Morten; Oltedal, Satu; Tjensvoll, Kjersti; Buhl, Tove; Smaaland, Rune; Garresori, Herish; Javle, Milind; Glenjen, Nils; Abelseth, Bente Kristin; Gilje, Bjørnar; Nordgård, Oddmund. Fragment size and level of cell-free DNA provide prognostic information in patients with advanced pancreatic cancer. GAP 2018; 2018-05-15 - 2018-05-17 HAUKELAND SUS |
|
|
|
||
| 4. | Lapin, Morten; Oltedal, Satu; Tjensvoll, Kjersti; Buhl, Tove; Smaaland, Rune; Garresori, Herish; Javle, Milind; Glenjen, Nils; Abelseth, Bente Kristin; Gilje, Bjørnar; Nordgård, Oddmund. Fragment size and level of cell-free DNA provide prognostic information in patients with advanced pancreatic cancer. AACR Annual Meeting 2018; 2018-04-14 - 2018-04-18 HAUKELAND SUS |
|
|
|
||
| 5. | Oltedal, Satu; Kørner, Hartwig; Aasprong, Ole Gunnar; Hussain, Israr; Tjensvoll, Kjersti; Smaaland, Rune; Søreide, Jon Arne; Søreide, Kjetil; Lothe, Ragnhild A; Heikkilä, Reino; Gilje, Bjørnar; Nordgård, Oddmund. The Prognostic Relevance of Sentinel Lymph Node Metastases Assessed by PHGR1 mRNA Quantification in Stage I to III Colon Cancer. Translational Oncology 2018 ;Volume 11.(2) p. 436-443 SUS UiB OUS |
|
|
|
||
| 6. | Oltedal, Satu; Skaland, Ivar; Maple-Grødem, Jodi; Tjensvoll, Kjersti; Janssen, Emiel; Gilje, Bjørnar; Smaaland, Rune; Heikkilä, Reino; Nordgård, Oddmund. Expression profiling and intracellular localization studies of the novel Proline-, Histidine-, and Glycine-rich protein 1 suggest an essential role in gastro-intestinal epithelium and a potential clinical application in colorectal cancer diagnostics. BMC Gastroenterology 2018 ;Volume 18.(26) p. - SUS UIS OUS |
|
|
2017
|
||
| 7. | Labori, Knut Jørgen; Lassen, Kristoffer; Hoem, Dag; Grønbech, Jon Erik; Søreide, Jon Arne; Mortensen, Kim Erlend; Smaaland, Rune; Sorbye, Halfdan; Verbeke, Caroline Sophie; Dueland, Svein. Neoadjuvant chemotherapy versus surgery first for resectable pancreatic cancer (Norwegian Pancreatic Cancer Trial - 1 (NorPACT-1)) – study protocol for a national multicentre randomized controlled trial. BMC Surgery 2017 ;Volume 17.(1) OUS HAUKELAND NTNU UiB UiO STO SUS UNN |
|
|
|
||
| 8. | Lapin, Morten; Tjensvoll, Kjersti; Oltedal, Satu; Javle, Milind; Smaaland, Rune; Gilje, Bjørnar; Nordgård, Oddmund. Single-Cell mRNA Profiling reveals Transcriptional Heterogeneity among Pancreatic Circulating Tumor Cells. AACR Annual Meeeting 2017; 2017-04-01 - 2017-04-05 SUS |
|
|
|
||
| 9. | Lapin, Morten; Tjensvoll, Kjersti; Oltedal, Satu; Javle, Milind; Smaaland, Rune; Gilje, Bjørnar; Nordgård, Oddmund. Single-Cell mRNA Profiling reveals Transcriptional Heterogeneity among Pancreatic Circulating Tumor Cells. GAP 2017 Conference; 2017-05-09 - 2017-05-11 SUS |
|
|
|
||
| 10. | Lapin, Morten; Tjensvoll, Kjersti; Oltedal, Satu; Javle, Milind; Smaaland, Rune; Gilje, Bjørnar; Nordgård, Oddmund. Single-cell mRNA profiling reveals transcriptional heterogeneity among pancreatic circulating tumour cells. BMC Cancer 2017 ;Volume 17:390. p. 1-10 SUS UIS |
|
|
|
||
| 11. | Oltedal, Satu; Kørner, Hartwig; Aasprong, Ole Gunnar; Hussain, Israr; Tjensvoll, Kjersti; Smaaland, Rune; Søreide, Jon Arne; Søreide, Kjetil; Lothe, Ragnhild A; Heikkilä, Reino; Gilje, Bjørnar; Nordgård, Oddmund. The Prognostic Relevance of Sentinel Lymph Node Metastases Assessed by PHGR1 mRNA Quantitation in Stage I-III Colon Cancer. GAP 2017 Conference; 2017-05-09 - 2017-05-11 OUS SUS UiB UiO |
|
|
2016
|
||
| 12. | Lapin, Morten; Tjensvoll, Kjersti; Oltedal, Satu; Buhl, Tove; Gilje, Bjørnar; Smaaland, Rune; Nordgård, Oddmund. MINDEC - an enhanced negative depletion strategy for circulating tumor cell enrichment. 10th ISMRC International Symposium on Minimal Residual Cancer; 2016-03-19 - 2016-03-21 SUS |
|
|
|
||
| 13. | Lapin, Morten; Tjensvoll, Kjersti; Oltedal, Satu; Buhl, Tove; Gilje, Bjørnar; Smaaland, Rune; Nordgård, Oddmund. MINDEC-An Enhanced Negative Depletion Strategy for Circulating Tumour Cell Enrichment. Scientific Reports 2016 ;Volume 6:28929. SUS UIS |
|
|
|
||
| 14. | Tjensvoll, Kjersti; Lapin, Morten; Buhl, Tove; Oltedal, Satu; Berry, Katrine; Gilje, Bjørnar; Søreide, Jon Arne; Javle, Milind; Nordgård, Oddmund; Smaaland, Rune. Clinical relevance of circulating KRAS mutated DNA in plasma from patients with advanced pancreatic cancer. Molecular Oncology 2016 ;Volume 10.(4) p. 635-643 UiB SUS |
|
|
2015
|
||
| 15. | Berg, Marianne; Nordgård, Oddmund; Kørner, Hartwig; Oltedal, Satu; Smaaland, Rune; Søreide, Jon Arne; Søreide, Kjetil. Molecular subtypes in stage II-III colon cancer defined by genomic instability: Early recurrence-risk associated with a high copy-number variation and loss of RUNX3 and CDKN2A. PLOS ONE 2015 ;Volume 10.(4) SUS UIS UiB |
|
|
|
||
| 16. | Tjensvoll, Kjersti; Lapin, Morten; Buhl, Tove; Oltedal, Satu; Steen-Ottosen Berry, Katrine; Gilje, Bjørnar; Søreide, Jon Arne; Javle, Milind; Nordgård, Oddmund; Smaaland, Rune. Clinical relevance of circulating tumor DNA in plasma from pancreatic cancer patients. AACR Annual Meeting 2015; 2015-04-18 - 2015-04-22 SUS UiB |
|
|
|
||
| 17. | Tjensvoll, Kjersti; Lapin, Morten; Buhl, Tove; Oltedal, Satu; Steen-Ottosen Berry, Katrine; Gilje, Bjørnar; Søreide, Jon Arne; Javle, Milind; Nordgård, Oddmund; Smaaland, Rune. Clinical relevance of circulating tumor DNA in plasma from pancreatic cancer patients. MD Anderson Cancer Center Global Academic Programs Conference; 2015-04-14 - 2016-04-16 SUS UiB |
|
|
2014
|
||
| 18. | Gilje, Bjørnar; Nordgård, Oddmund; Tjensvoll, Kjersti; Borgen, Elin; Synnestvedt, Marit; Smaaland, Rune; Naume, Bjørn. Comparison of molecular and immunocytochemical methods for detection of disseminated tumor cells in bone marrow from early breast cancer patients. BMC Cancer 2014 ;Volume 14.(1) SUS OUS UiO |
|
|
|
||
| 19. | Søreide, Jon Arne; Grønbech, Jon Erik; Lassen, Kristoffer; Dueland, Svein; Smaaland, Rune; Gladhaug, Ivar Prydz; Hauge, Truls; Olstad, Marit; Drolsum, Anders; Eide, Tor Jacob; Skår, Åse; Klemp, Marianne. Nasjonalt handlingsprogram med retningslinjer for diagnostikk, behandling og oppfølging av pasienter med pancreaskreft. Oslo: Helsedirektoratet 2014 (ISBN 978-82-8081-296-4) 87 p. FHI NTNU OUS STO UiB UiO UiT |
|
|
|
||
| 20. | Tjensvoll, Kjersti; Nordgård, Oddmund; Smaaland, Rune. Circulating tumor cells in pancreatic cancer patients: Methods of detection and clinical implications. International Journal of Cancer 2014 ;Volume 134.(1) p. 1-8 SUS |
|
|
2013
|
||
| 21. | Berg, Marianne; Guriby, Marianne; Nordgård, Oddmund; Nedrebø, Bjørn Steinar Olden; Ahlquist, Terje Cruickshank; Smaaland, Rune; Oltedal, Satu; Søreide, Jon Arne; Kørner, Hartwig; Lothe, Ragnhild A; Søreide, Kjetil. Influence of microsatellite instability and KRAS and BRAF mutations on lymph node harvest in stage I–III colon cancers. Molecular medicine (Cambridge, Mass. Print) 2013 ;Volume 19. p. 286-293 UiB UiO OUS SUS |
|
|
|
||
| 22. | Gudlaugsson, Einar; Klos, Jan; Skaland, Ivar; Janssen, Emilius Adrianus Maria; Smaaland, Rune; Feng, Weiwei; Shao, Zhimin; Malpica, Anais; Baak, Jan P.A.. PROGNOSTIC COMPARISON OF THE PROLIFERATION MARKERS (MITOTIC ACTIVITY INDEX, PHOSPHOHISTONE H3, KI67), STEROID RECEPTORS, HER2, HIGH MOLECULAR WEIGHT CYTOKERATINS AND CLASSICAL PROGNOSTIC FACTORS IN T1-2N0M0 BREAST CANCER. Polish Journal of Pathology 2013 ;Volume 64.(1) p. 1-8 SUS |
|
|
|
||
| 23. | Innominato, Pasquale F.; Giacchetti, Sylvie; Moreau, Thierry; Bjarnason, Georg A.; Smaaland, Rune; Focan, Christian; Garufi, Carlo; Iacobelli, Stefano; Tampellini, Marco; Tumolo, Salvatore; Carvalho, Carlos; Karaboue, Abdoulaye; Poncet, Antoine; Spiegel, David; Levi, Francis Lévi. Fatigue and weight loss predict survival on circadian chemotherapy for metastatic colorectal cancer. Cancer 2013 ;Volume 119.(14) p. 2564-2573 UiB SUS |
|
|
|
||
| 24. | Nordgård, Oddmund; Dhillon, Gurpartap Singh; Solberg, Steinar; Jørgensen, Lars Hilmar; Halvorsen, Ann Rita; Smaaland, Rune; Brustugun, Odd Terje; Helland, Åslaug. Novel Molecular Tumor Cell Markers in Regional Lymph Nodes and Blood Samples from Patients Undergoing Surgery for Non-Small Cell Lung Cancer. PLOS ONE 2013 ;Volume 8.(5) p. - SUS UiO OUS |
|
|
|
||
| 25. | Tjensvoll, Kjersti; Reine, Kristin; Buhl, Tove; Gilje, Bjørnar; Oltedal, Satu; Smaaland, Rune; Nordgård, Oddmund. Circulating tumor cells as a potential biomarker fortreatment response and disease progression inpatients with locally advanced and metastaticpancreatic cancer: preliminary results. International symposium for minimal resdiual cancer 2013; 2013-09-25 - 2013-09-27 SUS |
|
|
2012
|
||
| 26. | Giacchetti, Sylvie; Dugué, Pierre A.; Innominato, Pasquale F; Bjarnason, Georg A; Focan, Christian; Garufi, Carlo; Tumolo, Salvatore; Coudert, Bruno; Iacobelli, Stefano; Smaaland, Rune; Tampellini, Marco; Adam, Rene; Moreau, Thierry; Levi, Francis. Sex moderates circadian chemotherapy effects on survival of patients with metastatic colorectal cancer: a meta-analysis. Annals of Oncology 2012 ;Volume 23.(12) p. 3110-3116 UiB SUS |
|
|
|
||
| 27. | Gudlaugsson, Einar; Skaland, Ivar; Janssen, Emilius Adrianus Maria; Smaaland, Rune; Shao, Zhiming; Malpica, Anais; Voorhorst, Feja J.; Baak, Jan P.A.. Comparison of the effect of different techniques for measurement of Ki67 proliferation on reproducibility and prognosis prediction accuracy in breast cancer. Histopathology 2012 ;Volume 61.(6) p. 1134-1144 SUS |
|
|
|
||
| 28. | Jonsdottir, Kristin; Zhang, Hui; Jhagroe, Darshni; Skaland, Ivar; Slewa, Aida; Björkblom, Benny; Coffey, Eleanor T; Gudlaugsson, Einar; Smaaland, Rune; Janssen, Emilius Adrianus Maria; Baak, Jan P.A.. The prognostic value of MARCKS-like 1 in lymph node-negative breast cancer. Breast Cancer Research and Treatment 2012 ;Volume 135.(2) p. 381-390 SUS UiB |
|
|
|
||
| 29. | Nordgård, Oddmund; Oltedal, Satu; Aasprong, Ole Gunnar; Søreide, Jon Arne; Søreide, Kjetil; Tjensvoll, Kjersti; Gilje, Bjørnar; Heikkilä, Reino; Guriby, Marianne; Lothe, Ragnhild A; Smaaland, Rune; Kørner, Hartwig. Prognostic relevance of occult metastases detected by cytokeratin 20 and mucin 2 mRNA levels in sentinel lymph nodes from colon cancer patients. Annals of Surgical Oncology 2012 ;Volume 19.(12) p. 3719-3726 SUS OUS UiB UiO |
|
|
|
||
| 30. | Nordgård, Oddmund; Oltedal, Satu; Janssen, Emilius Adrianus Maria; Gilje, Bjørnar; Kørner, Hartwig; Tjensvoll, Kjersti; Smaaland, Rune. Comparison of a PNA clamp PCR and an ARMS/Scorpion PCR assay for detection of K-ras mutations. Diagnostic molecular pathology (Print) 2012 ;Volume 21.(1) p. 9-13 SUS UiB |
|
|
|
||
| 31. | Tjensvoll, Kjersti; Oltedal, Satu; Heikkilä, Reino; Kvaløy, Jan Terje; Gilje, Bjørnar; Reuben, James M.; Smaaland, Rune; Nordgård, Oddmund. Persistent tumor cells in bone marrow of non-metastatic breast cancer patients after primary surgery are associated with inferior outcome. BMC Cancer 2012 ;Volume 12. SUS UIS |
|
|
|
||
| 32. | Tjensvoll, Kjersti; Svendsen, Kine Netland; Reuben, James M.; Oltedal, Satu; Gilje, Bjørnar; Smaaland, Rune; Nordgård, Oddmund. miRNA expression profiling for identification of potential breast cancer biomarkers. Biomarkers 2012 ;Volume 17.(5) p. 463-470 SUS |
|
|
2011
|
||
| 33. | Gilje, Bjørnar; Nordgård, Oddmund; Tjensvoll, Kjersti; Janssen, Emilius Adrianus Maria; Søiland, Håvard; Smaaland, Rune; Baak, Jan P.A.. Mitotic activity and bone marrow micrometastases have independent prognostic value in node positive breast cancer patients. Breast Cancer Research and Treatment 2011 ;Volume 128.(1) p. 137-146 UiB SUS |
|
|
|
||
| 34. | Innominato, Pasquale F; Giacchetti, Sylvie; Moreau, Thierry; Smaaland, Rune; Focan, Christian; Bjarnason, Georg A; Garufi, Carlo; Iacobelli, Stefano; Tampellini, Marco; Tumolo, Salvatore; Carvalho, Carlos; Karaboue, Abdoulaye; Levi, Francis. Prediction of survival by neutropenia according to delivery schedule of oxaliplatin-5-fluorouracil-leucovorin for metastatic colorectal cancer in a randomized international trial (EORTC 05963). Chronobiology International 2011 ;Volume 28.(7) p. 586-600 SUS UiB |
|
|
|
||
| 35. | Lende, Tone Hoel; Janssen, Emilius Adrianus Maria; Gudlaugsson, Einar; Voorhorst, Feja; Smaaland, Rune; van Diest, Paul J; Søiland, Håvard; Baak, Jan P.A.. In patients younger than age 55 years with lymph node–negative breast cancer, proliferation by mitotic activity index is prognostically superior to adjuvant!. Journal of Clinical Oncology 2011 ;Volume 29.(7) p. 852-858 UiB SUS |
|
|
|
||
| 36. | Nordgård, Oddmund; Smaaland, Rune. SLN mapping in colorectal cancer. The Lancet Oncology 2011 ;Volume 12.(11) p. 990- SUS UiB |
|
|
|
||
| 37. | Nordgård, Oddmund; Ulas, Mona; Singh, Gurpartap; Fleischer, Thomas; Camilla, Sagerup; Smaaland, Rune; Brustugun, Odd Terje; Helland, Åslaug. Molecular tumour markers in regional lymph nodes and blood from patients undergoing surgery for non-small cell lung cancer. AACR Annual Meeting 2011; 2011-04-02 - 2011-04-06 OUS SUS |
|
|
|
||
| 38. | Oltedal, Satu; Aasprong, Ole Gunnar; Møller, Jannicke Horjen; Kørner, Hartwig; Gilje, Bjørnar; Tjensvoll, Kjersti; Birkemeyer, Elke; Heikkilä, Reino; Smaaland, Rune; Nordgård, Oddmund. Heterogeneous distribution of K-ras mutations in primary colon carcinomas: implications for EGFR-directed therapy. International Journal of Colorectal Disease 2011 ;Volume 26.(10) p. 1271-1277 SUS UiB |
|
|
|
||
| 39. | Tandstad, Torgrim; Smaaland, Rune; Solberg, Arne; Bremnes, Roy M.; Langberg, Carl W.; Laurell, Anna; Stierner, Ulrika; Ståhl, Olof; Cavallin-Ståhl, Eva; Klepp, Olbjørn; Dahl, Olav; Cohn-Cedermark, Gabriella. Management of Seminomatous Testicular Cancer: A Binational Prospective Population-Based Study From the Swedish Norwegian Testicular Cancer Study Group. Journal of Clinical Oncology 2011 ;Volume 29.(6) p. 719-725 UiB UiT STO UNN SUS HAUKELAND OUS HMR |
|
|
2010
|
||
| 40. | Hurmuzlu, Meysan Shukran; Øvrebø, Kjell Kåre; Wentzel-Larsen, Tore; Muren, Ludvig Paul; Viste, Asgaut; Smaaland, Rune. High-dose preoperative chemoradiotherapy in esophageal cancer patients does not increase postoperative pulmonary complications: Correlation with dose-volume histogram parameters. Radiotherapy and Oncology 2010 ;Volume 97.(1) p. 60-64 UiB HELSEFØRDE HAUKELAND SUS |
|
|
|
||
| 41. | Tjensvoll, Kjersti; Oltedal, Satu; Farmen, Ragne Kristin; Shammas, Fuad Victor; Heikkilä, Reino; Kvaløy, Jan Terje; Gilje, Bjørnar; Smaaland, Rune; Nordgård, Oddmund. Disseminated Tumor Cells in Bone Marrow Assessed by TWIST1, Cytokeratin 19, and Mammaglobin A mRNA Predict Clinical Outcome in Operable Breast Cancer Patients. Clinical Breast Cancer 2010 ;Volume 10.(5) p. 378-384 UIS SUS |
|
|
|
||
| 42. | Gilje, Bjørnar; Nordgård, Oddmund; Tjensvoll, Kjersti; Janssen, Emiel A.M.; Søiland, Håvard; Smaaland, Rune; Baak, Jan P.A.. Mitotic Activity Index and Bone Marrow Micrometastases is a Strong Prognostic Combination in Breast Cancer Patients. AACR Annual Meeting 2010; 2010-04-17 - 2010-04-21 SUS |
|
|
|
||
| 43. | Gudlaugsson, Einar; Skaland, Ivar; Janssen, Emilius Adrianus Maria; Smaaland, Rune; Søiland, Håvard; Baak, Jan P.A.. In operable node negative breast cancer patients under 71 years, lymph vessel invasion has no additional prognostic value to PhosphoHistone-3 proliferative activity. APMIS - Journal of Pathologiy, Microbiology and Immunology 2010 ;Volume 118.(3) p. 250-250 UiB SUS |
|
|
|
||
| 44. | Hurmuzlu, Meysan Shukran; Monge, Odd R; Smaaland, Rune; Viste, Asgaut. High-dose definitive concomitant chemoradiotherapy in non-metastatic locally advanced esophageal cancer: toxicity and outcome. Diseases of the esophagus 2010 ;Volume 23.(3) p. 244-252 UiB HAUKELAND |
|
|
|
||
| 45. | Hurmuzlu, Meysan Shukran; Øvrebø, Kjell Kåre; Monge, Odd R; Smaaland, Rune; Wentzel-Larsen, Tore; Viste, Asgaut. High-dose chemoradiotherapy followed by surgery versus surgery alone in esophageal cancer: a retrospective cohort study. World Journal of Surgical Oncology (WJSO) 2010 ;Volume 8. p. - UiB HAUKELAND HELSEFØRDE |
|
|
|
||
| 46. | Oltedal, Satu; Aasprong, Ole Gunnar; Møller, Jannicke Horjen; Kørner, Hartwig; Gilje, Bjørnar; Tjensvoll, Kjersti; Birkemeyer, Elke; Heikkila, Reino; Smaaland, Rune; Nordgård, Oddmund. Heterogeneous distribution of K-ras mutations in primary colon carcinomas: implications for EGFR-directed therapy. AACR Annual Meeting 2010; 2010-04-17 - 2010-04-21 SUS |
|
|
|
||
| 47. | Oltedal, Satu; Gilje, Bjørnar; Kørner, Hartwig; Aasprong, Ole Gunnar; Tjensvoll, Kjersti; Heikkilä, Reino; Smaaland, Rune; Nordgård, Oddmund. Detection of occult metastases in sentinel lymph nodes from colon cancer patients by K-ras mutation peptide nucleic acid clamp PCR. Annals of Surgery 2010 ;Volume 251.(6) p. 1087-1091 UiB SUS |
|
|
|
||
| 48. | Svendsen, Kine Netland; Nordgård, Oddmund; Tjensvoll, Kjersti; Reuben, James M.; Smaaland, Rune. Evaluation of specific micro-RNAs detected in bone marrow and peripheral blood plasma as prognostic markers in operable breast cancer patients. Global Academic Program Meeting 2010; 2010-04-13 - 2010-04-16 SUS |
|
|
2009
|
||
| 49. | Nordgård, Oddmund; Oltedal, Satu; Kørner, Hartwig; Aasprong, Ole Gunnar; Tjensvoll, Kjersti; Gilje, Bjørnar; Smaaland, Rune. Detection of tumor cells in sentinel lymph nodes from colon cancer patients by quantitative RT-PCR. AACR Annual Meeting 2009; 2009-04-18 - 2009-04-22 SUS |
|
|
2004
|
||
| 50. | Schoemaker, NE; Kuppens, IELM; Moiseyenko, V; Glimelius, B; Kjaer, M; Starkhammer, H; Richel, DJ; Smaaland, R; Bertelsen, K; Poulsen, JP; Voznyi, E; Norum, Jan; Fennelly, D; Tveit, KM; Garin, A; Gruia, G; Mourier, A; Sibaud, D; Lefebvre, P; Beijnen, JH; Schellens, JH; ten Bokkel Huinink, WW. A randomised phase II multicentre trial of irinotecan (CPT-11) using four different schedules in patients with metastatic colorectal cancer. British Journal of Cancer 2004 ;Volume 91. p. 1434-1441 UiT |
|